New Brunswick, New Jersey
May 14, 2002
Senesco
Technologies, Inc.
("Senesco" or the "Company") (OTCBB:SENO) today announced that
its application has been conditionally approved for listing on
the American Stock Exchange ("AMEX"). Pending the satisfaction
of certain initial listing requirements, the Company anticipates
commencing trading on AMEX on May 17, 2002, under the ticker
symbol "SNT." The Company's shares of common stock have been
trading on the OTC Bulletin Board since January 1999.
Bruce Galton, President and CEO of Senesco, stated, "We are
pursuing a listing on the American Stock Exchange to provide our
shareholders and prospective investors with, what we believe to
be, more efficient trading and greater visibility for the
Company. We believe these factors will help us toward our goal
of increasing shareholder value."
Senesco takes its name from the scientific term for the aging
of cells: senescence. The Company has developed technology that
regulates the onset of cell death. Delaying cell breakdown in
plants extends freshness after harvesting, while increasing crop
yields, plant size and resistance to environmental stress for
flowers, fruits and vegetables. The Company believes that its
technology can be used to develop superior strains of crops
without any modification other than delaying natural plant
senescence. Senesco has begun to explore ways to trigger or
delay cell death in mammals (apoptosis) to determine if the
technology is applicable in human medicine. Senesco partners
with leading-edge companies and earns research and development
fees for applying its gene-regulating platform technology to
enhance its partner's products. Senesco is headquartered in New
Brunswick, New Jersey, and has research laboratories at the
University of Waterloo in Ontario, Canada.
|